🕵️ Outlook Therapeutics, Inc. ($OTLK)
SEC insider & ownership activity, last 12 months · CIK 1649989 · every row links its SEC filing
Over the last 12 months insiders bought $7.9M with no open-market selling against it. Ghiath M. Sukhtian bought $7.5M in discretionary trades (May–Aug). One red-flag 8-K in the window: Delisting notice (3.01), Jun 26, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
5 buyers, $7.9M (8 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ghiath M. Sukhtian | 2 | $7.5M | 0 | – | Aug 12, 2026 |
| Kurt J. Hilzinger | 1 | $177K | 0 | – | May 26, 2026 |
| Sukhtian Faisal Ghiath | 2 | $150K | 0 | – | Jul 29, 2026 |
| Haddadin Yezan Munther | 2 | $39K | 0 | – | Jun 2, 2026 |
| Randy H. Thurman | 1 | $2K | 0 | – | May 26, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Ghiath M. Sukhtian | 16.4% | 13D | Aug 12, 2026 | filing ↗ | |
| GMS Ventures & Investments | 16.4% | 13D | Aug 12, 2026 | filing ↗ | |
| CVI Investments, Inc. | 9.9% | 13G | Aug 19, 2026 | filing ↗ | |
| Heights Capital Management, Inc. | 9.9% | 13G | Aug 19, 2026 | filing ↗ | |
| Sphera Global Healthcare Management LP | 5.2% | 13G | Mar 3, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 23, 2026 | filing ↗ |
| Earnings (2.02) | Aug 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2026 | filing ↗ |
| Other events (8.01) | Aug 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2026 | filing ↗ |
| Earnings (2.02) | Aug 12, 2026 | filing ↗ |
| Other events (8.01) | Aug 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2026 | filing ↗ |
| Other events (8.01) | Jul 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 21, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 16, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing ↗ |
| Delisting notice (3.01) | Jun 26, 2026 | filing ↗ |
| Other events (8.01) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Other events (8.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Other events (8.01) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Other events (8.01) | May 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 28, 2026 | filing ↗ |
| Other events (8.01) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Material agreement (1.01) | May 12, 2026 | filing ↗ |
| Agreement terminated (1.02) | May 12, 2026 | filing ↗ |